Cargando…

Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101

Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Peng, Li, Jingbao, Han, Feng, Duan, Gaofei, Lu, Xinzhi, Gu, Yuchao, Yu, Wengong
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072402/
https://www.ncbi.nlm.nih.gov/pubmed/21490923
http://dx.doi.org/10.1371/journal.pone.0018514
_version_ 1782201550126448640
author Jiang, Peng
Li, Jingbao
Han, Feng
Duan, Gaofei
Lu, Xinzhi
Gu, Yuchao
Yu, Wengong
author_facet Jiang, Peng
Li, Jingbao
Han, Feng
Duan, Gaofei
Lu, Xinzhi
Gu, Yuchao
Yu, Wengong
author_sort Jiang, Peng
collection PubMed
description Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.
format Text
id pubmed-3072402
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30724022011-04-13 Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101 Jiang, Peng Li, Jingbao Han, Feng Duan, Gaofei Lu, Xinzhi Gu, Yuchao Yu, Wengong PLoS One Research Article Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides. Public Library of Science 2011-04-07 /pmc/articles/PMC3072402/ /pubmed/21490923 http://dx.doi.org/10.1371/journal.pone.0018514 Text en Jiang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jiang, Peng
Li, Jingbao
Han, Feng
Duan, Gaofei
Lu, Xinzhi
Gu, Yuchao
Yu, Wengong
Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title_full Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title_fullStr Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title_full_unstemmed Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title_short Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
title_sort antibiofilm activity of an exopolysaccharide from marine bacterium vibrio sp. qy101
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072402/
https://www.ncbi.nlm.nih.gov/pubmed/21490923
http://dx.doi.org/10.1371/journal.pone.0018514
work_keys_str_mv AT jiangpeng antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT lijingbao antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT hanfeng antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT duangaofei antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT luxinzhi antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT guyuchao antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101
AT yuwengong antibiofilmactivityofanexopolysaccharidefrommarinebacteriumvibriospqy101